Product purity assessment is a critical analytical process that determines the exact composition, impurity profile, and overall quality of chemical, pharmaceutical, and material products. Our comprehensive purity assessment solution combines advanced chromatographic, spectroscopic, and thermal techniques to deliver accurate, reproducible, and regulatory-compliant results. From raw material verification to final product release testing, this solution supports manufacturers, researchers, and quality control teams in making confident decisions about product integrity and safety.
Technical Overview
Product purity assessment refers to the systematic analytical evaluation of a substance to determine its actual content of the target compound and to identify and quantify any impurities present. Purity is a fundamental quality attribute that directly impacts product performance, safety, regulatory compliance, and commercial value across industries such as pharmaceuticals, fine chemicals, biotechnology, food science, and advanced materials.
A scientifically rigorous purity assessment solution integrates multiple orthogonal analytical techniques, because no single method can fully characterize the purity of a complex substance. For example, high-performance liquid chromatography (HPLC) may reveal organic impurities, while thermogravimetric analysis (TGA) detects residual solvents and moisture, and inductively coupled plasma mass spectrometry (ICP-MS) quantifies trace elemental contaminants. By combining complementary methods, the total purity picture can be established with high confidence.
A well-designed purity assessment scheme typically includes the following workflow stages:
- Sample intake and documentation: recording sample information, storage conditions, and intended purpose of the analysis.
- Method selection and development: choosing appropriate techniques based on sample properties, expected impurities, and applicable regulatory standards.
- Analytical testing: performing quantitative and qualitative measurements using validated instruments and procedures.
- Data interpretation: calculating purity values, identifying impurities, and cross-verifying results from orthogonal methods.
- Reporting: issuing a complete analytical report with purity conclusions, chromatograms, spectra, and methodological details.
The final purity result is typically expressed as a mass percentage or area percentage, and where applicable, results are reported on both an as-received basis and a dry basis to account for moisture and volatile content.
Testing Samples
The purity assessment solution is applicable to a broad range of sample types encountered in research, development, and manufacturing environments. Representative sample categories include:
Pharmaceutical and Biopharmaceutical Samples
Active pharmaceutical ingredients (APIs), intermediates, reference standards, excipients, and drug products are routinely evaluated for purity and impurity profiles in accordance with pharmacopeial requirements such as USP, EP, and ChP. Biopharmaceutical samples including peptides, proteins, and oligonucleotides require specialized chromatographic and mass spectrometric approaches.
Organic and Fine Chemicals
Synthetic intermediates, catalysts, ligands, agrochemicals, dyes, and specialty chemicals are assessed to verify reaction completeness, identify by-products, and confirm specifications for downstream use.
Inorganic Compounds and Materials
Salts, oxides, metals, ceramics, nanomaterials, and battery materials are characterized for elemental purity, phase composition, and trace contamination using spectroscopic and diffraction techniques.
Natural Products and Food-Related Samples
Plant extracts, natural product isolates, food additives, and nutraceutical ingredients are evaluated for active component content and adulterants.
Polymers and Reference Materials
Monomers, polymer additives, and certified reference material candidates require thorough purity assignment to support calibration and metrological traceability.
Testing Items
Depending on the sample matrix and regulatory context, a comprehensive purity assessment may include the following testing items:
- Assay of main component: quantitative determination of the target compound content, reported as weight percentage.
- Related substances and organic impurities: identification and quantification of structurally related impurities, degradation products, and synthetic by-products.
- Residual solvents: determination of volatile organic solvents remaining from synthesis or purification, tested against ICH Q3C limits where applicable.
- Water content: measurement of moisture using Karl Fischer titration or thermogravimetric analysis, often reported separately from other volatiles.
- Inorganic impurities and elemental contaminants: quantification of heavy metals and trace elements such as lead, arsenic, cadmium, and mercury in line with ICH Q3D guidelines.
- Non-volatile residue and ash content: assessment of inorganic residue after ignition or evaporation.
- Isomeric composition: evaluation of enantiomeric or geometric isomer ratios using chiral chromatography or NMR spectroscopy.
- Counter-ion and salt form confirmation: verification of salt stoichiometry and counter-ion identity.
- Structural confirmation: confirmation of molecular identity supporting the purity assignment, using NMR, mass spectrometry, and infrared spectroscopy.
Each testing item contributes to the overall purity balance, and the mass balance approach—combining assay value with all quantified impurities—provides a robust cross-check of the reported purity.
Testing Methods
Method selection depends on the physicochemical properties of the analyte, the nature of expected impurities, sensitivity requirements, and regulatory expectations. The core techniques employed in this solution include:
Chromatographic Methods
High-performance liquid chromatography (HPLC) with UV, diode-array (DAD), refractive index (RI), evaporative light scattering (ELSD), or charged aerosol detection (CAD) is the workhorse technique for organic purity determination, offering high resolution and quantitative accuracy. Ultra-high-performance liquid chromatography (UHPLC) provides faster separations with improved sensitivity. Gas chromatography (GC) with flame ionization detection (FID) or thermal conductivity detection (TCD) is preferred for volatile compounds and residual solvent analysis. Chiral HPLC and GC are applied for enantiomeric purity, and ion chromatography (IC) serves ionic species and counter-ions.
Hyphenated Mass Spectrometry
LC-MS and LC-MS/MS enable impurity identification through accurate mass measurement and fragmentation analysis, even at trace levels. GC-MS is applied for volatile impurity profiling and unknown identification. High-resolution mass spectrometry (HRMS) supports structural elucidation of degradation products.
Spectroscopic Methods
Nuclear magnetic resonance spectroscopy (1H-qNMR) has become a gold-standard quantitative purity method because it provides absolute quantification without compound-specific reference standards. UV-Vis spectrophotometry supports simple assay measurements, and Fourier-transform infrared spectroscopy (FT-IR) confirms functional group identity and detects specific adulterants.
Elemental and Inorganic Analysis
Inductively coupled plasma optical emission spectrometry (ICP-OES) and ICP-MS deliver multi-element quantification from percent to parts-per-trillion levels. Atomic absorption spectroscopy (AAS) provides targeted elemental analysis, and X-ray fluorescence (XRF) offers non-destructive elemental screening. X-ray diffraction (XRD) confirms crystalline phase purity in solid materials.
Thermal and Classical Methods
Differential scanning calorimetry (DSC) can determine purity of high-purity crystalline substances (typically above 98.5 mole percent) based on melting behavior depression. Thermogravimetric analysis (TGA) quantifies volatile content, and Karl Fischer titration delivers precise water determination. Classical methods including potentiometric titration, gravimetric analysis, and loss on drying remain valuable for specific sample types.
Method Validation
Where regulatory submission is intended, methods are validated for specificity, linearity, accuracy, precision, range, quantitation limit, detection limit, and robustness in accordance with ICH Q2(R2) guidelines. System suitability testing is performed before each analytical sequence to ensure ongoing method performance.
Applications
The product purity assessment solution serves diverse practical needs across industries and research fields:
- Pharmaceutical quality control: release testing of APIs and drug products, impurity profiling against ICH Q3A/Q3B thresholds, stability-indicating method support, and pharmacopeial compliance verification.
- R&D and process development: monitoring reaction conversion, optimizing purification conditions such as recrystallization or chromatography, and comparing synthetic routes by impurity fingerprinting.
- Reference standard qualification: assigning purity values for in-house standards and characterizing certified reference materials using mass balance and qNMR approaches.
- Supplier verification and incoming inspection: confirming that purchased raw materials and intermediates meet contractual purity specifications before use in production.
- Regulatory submission support: generating impurity data packages for IND, NDA, ANDA, and REACH submissions with complete documentation and audit trails.
- Failure investigation: root-cause analysis of out-of-specification results, contamination events, and customer complaints through targeted impurity identification.
- Advanced materials development: verifying the purity of precursors for semiconductors, catalysts, battery electrolytes, and nanomaterials where trace impurities critically affect performance.
FAQ
What purity level can be reported?
With validated quantitative methods such as qNMR and mass balance approaches, purity can typically be determined with a relative uncertainty of approximately one percent or better. HPLC area purity is reported with high precision, though it should be noted that area percent does not account for impurities with significantly different response factors, which is why orthogonal confirmation is recommended.
How much sample is required for a complete purity assessment?
A comprehensive assessment covering assay, related substances, residual solvents, water, and elemental impurities generally requires 100 to 500 milligrams of sample, depending on the number of techniques applied. Specific requirements are confirmed during project scoping, and trace-level or high-value samples can often be accommodated with micro-analytical workflows.
What is the difference between area purity and absolute purity?
Area purity reflects the percentage of the total chromatographic peak area attributed to the main component and does not account for non-detected impurities such as water, inorganic residues, or solvents. Absolute purity, determined by quantitative methods against certified reference standards or by qNMR, expresses the true mass fraction of the target compound and is required for most regulatory and metrological purposes.
How long does a typical purity assessment take?
Standard testing using established methods is generally completed within five to ten working days. Projects requiring method development, impurity identification, or validation may extend from two to six weeks depending on complexity.
Can unknown impurities be identified?
Yes. Unknown impurities detected during screening can be characterized using high-resolution LC-MS/MS or GC-MS analysis, supported by NMR where sufficient material can be isolated. Tentative structural assignments are provided with confidence levels, and definitive identification may require isolation or synthesis of reference material.
Are the results accepted by regulatory authorities?
Testing is performed under GLP-compliant or ISO/IEC 17025-accredited quality systems with validated methods, calibrated instruments, and complete data documentation, ensuring that reports are suitable for submission to regulatory agencies such as the FDA, EMA, and NMPA.
What standards or guidelines are followed?
Methods follow current pharmacopeias (USP, EP, JP, ChP), ICH guidelines including Q2(R2), Q3A, Q3B, Q3C, and Q3D, and where relevant, ASTM and ISO standards. Client-specified internal methods can also be executed and validated as needed.